Provided by Tiger Fintech (Singapore) Pte. Ltd.

DAWNRAYS PHARMA

1.310
+0.0201.55%
Volume:660.00K
Turnover:864.08K
Market Cap:1.97B
PE:3.20
High:1.320
Open:1.310
Low:1.300
Close:1.290
Loading ...

Company Profile

Company Name:
DAWNRAYS PHARMA
Exchange:
SEHK
Establishment Date:
1995
Employees:
1183
Office Location:
CNT Tower,Units 3001-02, 30/F,338 Hennessy Road,Wan Chai,Hong Kong
Zip Code:
- -
Fax:
- -
Introduction:
Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines. The products include intermediate pharmaceutical, bulk medicines and finished drugs. The Company operates its business through two segments. The Intermediates and Bulk Medicines segment is engaged in the manufacture and sale of intermediates and bulk medicines. The Finished Drugs segment is engaged in the manufacture and sale of finished drugs, including antibiotics finished drugs and non-antibiotics finished drugs.

Directors

Name
Position
LI Kei Ling
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
HUNG Yung Lai
Executive Director
LO Tung Sing Tony
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
EDE, Ronald Hao Xi
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
LIN Ming Yi
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
LEUNG Hong Man
Director

Shareholders

Name
Position
YU Li Wei
General Manager
WU Yi Juan
CFO
PANG Kit Ling
Corporate Secretary